00000000nam 22000008i 4500
0019.917180
003CaOODSP
00520250228110505
006m     o  d f      
007cr |||||||||||
008221110t20222022oncd    ob   f000 0 eng d
020 |a9780660462219
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-422/2022E-PDF
24500|aAccess to cannabis for medical purposes in Canada : |bgathering information on views and practices of patients and health care practitioners - final report / |cprepared for Health Canada.
24617|aAccess to cannabis for medical purposes in Canada
264 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2022.
264 4|c©2022
300 |a1 online resource (185 pages) : |echarts + executive summary (9 unnumbered pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Accès au cannabis à des fins médicales au Canada : Recueillir des renseignements sur les perspectives et les pratiques des patients et des professionnels de la santé – rapport final.
500 |a"Supplier Name: Phoenix SPI."
500 |a"Contract Number: HT372-214981/001/CY."
500 |a"Registration number: POR 093-21."
500 |a"October 2022."
504 |aIncludes bibliographical references.
650 0|aCannabis|zCanada|xPublic opinion.
650 0|aMarijuana|zCanada|xPublic opinion.
650 0|aMarijuana|xTherapeutic use|zCanada|xPublic opinion.
650 0|aPublic opinion|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
7102 |aPhoenix Strategic Perspectives Inc., |econsultant.
77508|tAccès au cannabis à des fins médicales au Canada : |w(CaOODSP)9.917184
85640|qPDF|s7.87 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H14-422-2022-eng.pdf|zReport
85640|qPDF|s797 KB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H14-422-2022-1-eng.pdf|zExecutive summary
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/093-21-e/POR093-21-Report.html|zReport
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2022/093-21-e/summary/POR093-21-Summary.html|zExecutive summary